Akynzeo Approval History
FDA Approved: Yes (First approved October 10, 2014)
Brand name: Akynzeo
Generic name: netupitant and palonosetron
Dosage form: Capsules
Company: Helsinn Healthcare SA
Treatment for: Nausea/Vomiting, Chemotherapy Induced
Akynzeo (netupitant and palonosetron) is a substance P/neurokinin 1 (NK1) receptor antagonist and serotonin-3 (5-HT3) receptor antagonist fixed-dose combination indicated for the prevention of chemotherapy-induced nausea and vomiting (CINV).
Development History and FDA Approval Process for Akynzeo
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.